Key result
A single oral dose of nisoldipine reduced ST segment depression at peak exercise from 0.21 mV to 0.10 mV in patients with stable angina pectoris.
Why the study?
Does single oral administration of 10 mg nisoldipine improve exercise-induced hemodynamic changes and ST segment depression in patients with stable angina pectoris?
Does single oral administration of 10 mg nisoldipine improve exercise-induced hemodynamic changes and ST segment depression in patients with stable angina pectoris?
A single 10 mg oral dose of nisoldipine effectively reduces exercise-induced ST depression and improves hemodynamics by lowering systemic vascular resistance in patients with stable angina.
Answers are grounded in this paper and cite their sources.
May reduce acute exercise ischemia in stable angina; leaves open need for RCTs on chronic use and outcomes.
To examine antianginal effects of nisoldipine, a new calcium channel blocker, 10 patientswith effort angina pectoris were studied. Hemodynamic data were obtained by anginalimited supine multistage bicycle ergometer exercise testing before and after single oraladministration of 10mg of nisoldipine.After nisoldipine, chest pain at peak exercise disappeared or abated, and ST segmentat peak exercise also showed less significant depression. At rest and peak exercise, meanblood pressure, pulmonary artery wedge pressure and systemic vascular resistance decreasedsignificantly, whereas, heart rate increased significantly after nisoldipine. At rest, cardiacindex increased significantly after nisoldipine. At peak exercise, coronary sinus flowtended to increase after nisoldipine. Stroke volume index and myocardial oxygen consumption did not change significantly. Average time to peak plasma nisoldipine concentration was 1.6 hours and average peak plasma concentration was 13.8ng/ml with anelimination half-life of 1.6 hours.Thus, nisoldipine is an active antianginal drug; its major mechanism of action is to lowersystemic vascular resistance and to improve coronary blood flow during exercise.
No takes yet. Share an insight, caveat, or question.
Kamihara et al. (1988) studied Stable angina pectoris (n=10). Nisoldipine vs. Baseline (before administration) was evaluated on ST segment depression at peak exercise (mV) (p=<0.01). A single oral dose of nisoldipine reduced ST segment depression at peak exercise from 0.21 mV to 0.10 mV in patients with stable angina pectoris.
Synapse has enriched 10 related papers. Consider them for comparative context: